Literature DB >> 66990

Therapeutic approaches in malignant mesothelioma.

S S Legha, F M Muggia.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 66990     DOI: 10.1016/s0305-7372(77)80016-9

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  5 in total

Review 1.  Chemotherapy in malignant mesothelioma: a review.

Authors:  A Krarup-Hansen; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

2.  Treatment of diffuse pleural malignant mesothelioma by cis dichloro diammine platinum (C.D.D.P.) in nine patients.

Authors:  G Dabouis; B Le Mevel; J Corroller
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

3.  Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients.

Authors:  M R Law; A Gregor; M E Hodson; H J Bloom; M Turner-Warwick
Journal:  Thorax       Date:  1984-04       Impact factor: 9.139

4.  Menogaril in the treatment of malignant mesothelioma: a phase II study.

Authors:  C A Hudis; D P Kelsen
Journal:  Invest New Drugs       Date:  1992-07       Impact factor: 3.850

5.  Intraperitoneal cisplatin and etoposide in peritoneal mesothelioma: favorable outcome with a multimodality approach.

Authors:  C J Langer; N Rosenblum; M Hogan; S Nash; P Bagchi; F P LaCreta; R Catalano; R L Comis; P J O'Dwyer
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.